AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3

Siaglide-M 1000mg+50mg Tablet PR

Prescription Icon
Prescription Required

Marketer

Abbott

Salt Composition

Sitagliptin (50mg) + Metformin (1000mg)

Overview Siaglide-M 1000mg+50mg Tablet PR

Combiflex-D 1000mg+50mg tablets are a dual-action medication managing elevated blood glucose in individuals with type 2 diabetes. This dual approach helps mitigate severe diabetic complications like renal impairment and vision loss, potentially lessening the risk of cardiovascular events. Combiflex-D 1000mg+50mg tablets may be used independently or in conjunction with other antidiabetic therapies. Optimal results are achieved with a balanced diet and regular physical activity. Dosage is individualized based on your health status, glucose levels, and existing medications. Ingesting it with food minimizes gastrointestinal distress. Consistent daily administration at the same time maximizes efficacy; discontinuation should only occur under medical guidance. Adherence to the prescribed diet and exercise regimen is crucial for successful diabetes management; lifestyle significantly impacts glucose control. Common side effects include nausea, vomiting, diarrhea, abdominal discomfort, headache, and pharyngitis. Hypoglycemia is a potential adverse effect, particularly when combined with insulin or sulfonylureas; understanding hypoglycemia's signs and management is essential. This medication isn't universally suitable. Prior to commencing treatment, inform your physician of any history of renal, hepatic, or cardiac disease, pancreatic issues, or significant alcohol consumption. Pregnant or lactating individuals should seek medical counsel before use. Potential drug interactions exist; disclose all medications to your doctor to ensure safety. Alcohol should be minimized due to its hypoglycemic effect. Your doctor will monitor renal function and blood glucose levels throughout treatment.

Primary Ingredients of Siaglide-M 1000mg+50mg Tablet PR

The provided text is "undefined," therefore no rephrasing is possible.

Uses of Siaglide-M 1000mg+50mg Tablet PR

Managing type 2 diabetes

Major Benefits of Siaglide-M 1000mg+50mg Tablet PR:

Follow your physician's instructions or consult the product label for usage guidance. Administer Siaglide-M 1000mg+50mg Tablet PR with a meal.

Common Side effects of Siaglide-M 1000mg+50mg Tablet PR:

  • Decreased appetite
  • Vomiting
  • Upper respiratory tract infection
  • Hypoglycemia (low blood glucose level)
  • Abdominal bloating
  • Nausea
  • Diarrhea

How to use Siaglide-M 1000mg+50mg Tablet PR:

Follow your physician's instructions or consult the product labeling for usage guidelines. Administer Siaglide-M 1000mg+50mg Tablet PR with a meal.

How Siaglide-M 1000mg+50mg Tablet PR works:

Siaglide-M 1000mg+50mg tablets combine sitagliptin and metformin to manage blood glucose levels. Sitagliptin enhances insulin production by the pancreas, improves insulin utilization, and decreases hepatic glucose output. Metformin, a biguanide, reduces liver glucose production, slows intestinal glucose absorption, and boosts insulin sensitivity. This dual action offers superior glycemic control.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Siaglide-M 1000mg+50mg tablets with alcohol is inadvisable.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Siaglide-M 1000mg+50mg Tablet PR during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to the fetus. A physician will assess the potential advantages against any risks prior to prescribing this medication. Seek medical advice before using this drug.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Use of Siaglide-M 1000mg+50mg tablets during breastfeeding is likely inadvisable. Available data from human studies indicate potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingCAUTION

Driving may be impaired by excessively low or high blood sugar levels. Refrain from driving if such symptoms arise.

KidneyKidneyCAUTION

Patients with kidney impairment should use Siaglide-M 1000mg+50mg Tablet PR cautiously, potentially requiring dosage modification. Physician consultation is essential. Siaglide-M 1000mg+50mg Tablet PR is contraindicated in those with severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverUNSAFE

Use of Siaglide-M 1000mg+50mg tablets is likely inadvisable for individuals with hepatic impairment and should be avoided. Physician consultation is recommended.

What if you forget to take Siaglide-M 1000mg+50mg Tablet PR :

Should you forget a Siaglide-M 1000mg+50mg Tablet PR dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Avoid taking a double dose.

Facts to Know About Siaglide-M 1000mg+50mg Tablet PR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Siaglide-M 1000mg+50mg Tablet PR

Siaglide-M 1000mg+50mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This combination improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. This medication is unsuitable for individuals under 18.
Prolonged use of Siaglide-M 1000mg+50mg Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Siaglide-M 1000mg+50mg Tablet PR commonly causes hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use may also result in vitamin B12 deficiency.
Patients with known allergies to Siaglide-M 1000mg+50mg Tablet PR components or excipients should not use this medication. It should also be avoided by those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Siaglide-M 1000mg+50mg Tablet PR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Sitagliptin/Metformin (Siaglide-M 1000mg+50mg Tablet PR) can cause lactic acidosis (MALA), a serious medical emergency characterized by excessive blood lactic acid. This rare side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience these, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Siaglide-M 1000mg+50mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when combined with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Siaglide-M 1000mg+50mg Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Siaglide-M 1000mg+50mg Tablet PR components or excipients, or those with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis should not use this medication.
Combining Siaglide-M 1000mg+50mg Tablet PR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Siaglide-M 1000mg+50mg Tablet PR) can cause lactic acidosis (MALA, Metformin-associated lactic acidosis), a serious medical emergency resulting from excessive blood lactic acid. This rare side effect necessitates caution in patients with kidney disease, the elderly, or those who consume significant alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. Should these symptoms occur, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Siaglide-M 1000mg+50mg Tablet PR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and balance problems), urinary issues, and cognitive changes. To mitigate these risks, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication; ensure it's inaccessible to children, pets, and others.
Siaglide-M 1000mg+50mg tablets combine sitagliptin and metformin to manage type 2 diabetes in adults. This treatment improves blood sugar control when used with diet and exercise. Metformin reduces liver glucose production and enhances insulin sensitivity, while sitagliptin increases insulin release by inhibiting DPP-4. It's not suitable for individuals under 18.
Siaglide-M 1000mg+50mg Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, headache, and upper respiratory tract infections. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Patients with known allergies to Siaglide-M 1000mg+50mg Tablet PR components or excipients should not use this medication. Its use is contraindicated in patients with severe kidney or liver impairment, congestive heart failure, lactic acidosis, or diabetic ketoacidosis.
Combining Siaglide-M 1000mg+50mg Tablet PR with alcohol is unsafe and may heighten the risk of lactic acidosis.
Sitagliptin/Metformin (Siaglide-M 1000mg+50mg Tablet PR) can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare side effect necessitates caution in patients with kidney disease, older adults, or those who consume excessive alcohol. Symptoms include muscle pain/weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If experienced, discontinue Sitagliptin/Metformin and seek immediate medical attention.
Prolonged use of Siaglide-M 1000mg+50mg Tablet PR can lead to vitamin B12 deficiency by hindering its absorption. This deficiency may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, urinary issues, cognitive changes, and ataxia), if left unaddressed. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Store this medication in its original, tightly closed container, following the storage instructions on the label or packaging. Discard any unused medication and ensure it's inaccessible to children, pets, and others.
Siaglide-M 1000mg+50mg Ta...
333